Wolverine Asset Management LLC Edwards Lifesciences Corp Transaction History

Wolverine Asset Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$83.84 - $104.76 $112,764 - $140,902	-1,345 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$78.68 - $90.67 $22,266 - $25,659	283 Added 26.65%	1,345 $112,000
Q4 2020 Feb 12, 2021	SELL	$71.69 - $91.23 $48,032 - $61,124	-670 Reduced 38.68%	1,062 $96,000
Q3 2020 Nov 13, 2020	BUY	$67.19 - $87.44 $114,491 - $148,997	1,704 Added 6085.71%	1,732 $138,000
Q2 2020 Aug 13, 2020	BUY	$57.54 - $76.95 $1,611 - $2,154	28 New	28 $1,000

1,351

455M

9.76M

3.92M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $41.9B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Wolverine Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Asset Management LLC with notifications on news.